Altai Capital Management Boosts Stake in OraSure Technologies

Got story updates? Submit your updates here. ›

Altai Capital Management L.P., an institutional investor, has increased its stake in OraSure Technologies, Inc. (NASDAQ:OSUR) by 73.4% during the third quarter of 2025, according to a recent SEC filing. Altai Capital now owns 3,748,836 shares of the medical instruments supplier, making it the company's second-largest position and representing approximately 5.23% of OraSure's outstanding shares.

Why it matters

The significant increase in Altai Capital's stake in OraSure Technologies suggests the institutional investor sees potential in the company's medical diagnostic products, including its flagship OraQuick rapid HIV test. OraSure's performance and growth prospects are closely watched by investors as the company navigates the competitive point-of-care testing market.

The details

Altai Capital Management acquired an additional 1,586,488 shares of OraSure Technologies during the third quarter, bringing its total holdings to 3,748,836 shares. This investment represents approximately 23.6% of Altai Capital's overall portfolio. OraSure Technologies is a Bethlehem, Pennsylvania-based company that specializes in the development and commercialization of point-of-care and self-testing diagnostic products.

• Altai Capital Management increased its stake in OraSure Technologies during the third quarter of 2025.